Trapidil: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
'''Trapidil''' is a [[ | == Trapidil == | ||
[[File:Trapidil.svg|thumb|Chemical structure of Trapidil]] | |||
'''Trapidil''' is a [[pharmaceutical drug]] that acts as a [[vasodilator]] and [[antiplatelet]] agent. It is primarily used in the treatment of [[cardiovascular diseases]], such as [[angina pectoris]] and [[coronary artery disease]]. | |||
== Mechanism of Action == | == Mechanism of Action == | ||
Trapidil functions by inhibiting the action of [[platelet-derived growth factor]] (PDGF), which plays a significant role in the proliferation of [[smooth muscle cells]] and the development of [[atherosclerosis]]. By blocking PDGF, trapidil helps to prevent the narrowing of blood vessels and improves blood flow. Additionally, trapidil has been shown to inhibit [[phosphodiesterase]], leading to increased levels of [[cyclic adenosine monophosphate]] (cAMP) in platelets, which reduces platelet aggregation. | |||
Trapidil | |||
== Clinical Uses == | == Clinical Uses == | ||
Trapidil is used in the management of various cardiovascular conditions. It is particularly effective in treating [[angina]], a condition characterized by chest pain due to reduced blood flow to the heart. Trapidil is also used to prevent [[restenosis]] following [[angioplasty]], a procedure to open narrowed or blocked blood vessels. | |||
Trapidil is used in the | |||
== Side Effects == | == Side Effects == | ||
Common side effects of trapidil include [[headache]], [[dizziness]], and [[gastrointestinal disturbances]]. In some cases, patients may experience [[hypotension]] or [[allergic reactions]]. It is important for patients to be monitored for any adverse effects during treatment. | |||
== Related Research == | |||
Research on trapidil has explored its potential benefits in other areas, such as its anti-inflammatory properties and its role in [[cancer]] treatment. Studies have suggested that trapidil may inhibit tumor growth by blocking PDGF receptors on cancer cells. | |||
== | == Related Pages == | ||
* [[Vasodilator]] | |||
* [[Antiplatelet drug]] | |||
* [[Angina pectoris]] | |||
* [[Coronary artery disease]] | |||
== References == | |||
{{Reflist}} | |||
[[Category:Vasodilators]] | [[Category:Vasodilators]] | ||
[[Category: | [[Category:Antiplatelet drugs]] | ||
[[Category:Cardiovascular drugs]] | |||
Revision as of 19:59, 8 February 2025
Trapidil

Trapidil is a pharmaceutical drug that acts as a vasodilator and antiplatelet agent. It is primarily used in the treatment of cardiovascular diseases, such as angina pectoris and coronary artery disease.
Mechanism of Action
Trapidil functions by inhibiting the action of platelet-derived growth factor (PDGF), which plays a significant role in the proliferation of smooth muscle cells and the development of atherosclerosis. By blocking PDGF, trapidil helps to prevent the narrowing of blood vessels and improves blood flow. Additionally, trapidil has been shown to inhibit phosphodiesterase, leading to increased levels of cyclic adenosine monophosphate (cAMP) in platelets, which reduces platelet aggregation.
Clinical Uses
Trapidil is used in the management of various cardiovascular conditions. It is particularly effective in treating angina, a condition characterized by chest pain due to reduced blood flow to the heart. Trapidil is also used to prevent restenosis following angioplasty, a procedure to open narrowed or blocked blood vessels.
Side Effects
Common side effects of trapidil include headache, dizziness, and gastrointestinal disturbances. In some cases, patients may experience hypotension or allergic reactions. It is important for patients to be monitored for any adverse effects during treatment.
Related Research
Research on trapidil has explored its potential benefits in other areas, such as its anti-inflammatory properties and its role in cancer treatment. Studies have suggested that trapidil may inhibit tumor growth by blocking PDGF receptors on cancer cells.
Related Pages
References
<references group="" responsive="1"></references>